ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,509.01
0.62%
Dow Jones
39,331.85
0.41%
US Dollar vs MXN
18.2715
0.02%
Brent Oil
86.52
0.09%
Bitcoin
60,814.63
-1.95%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
03/07/202400:00Business WireCTP N.V. notice of H1-2024 results
03/07/202400:00Business Wireシカモア・ツリー・キャピタル・パートナーズ「Best US Boutique CLO Manager Award」を受賞
03/07/202400:00GlobeNewswire Inc.Start of Day Message
03/07/202400:00Business WireElliptic Labs Signs Expansion Contract with Commercial Segment of PC Customer
03/07/202400:00Business WireBenevolentAI: Leadership Team Change
03/07/202400:00GlobeNewswire Inc.Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPDBIT:SANFSanofi
03/07/202400:00GlobeNewswire Inc.Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPDNASDAQ:REGNRegeneron Pharmaceuticals Inc
03/07/202400:00GlobeNewswire Inc.Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenneTG:SNWSanofi
03/07/202400:00PR Newswire (US)iTRAK 5750 Intelligent Track System from Rockwell Automation Enables Faster, More Flexible Motion Across Heavier PayloadsNYSE:ROKRockwell Automation Inc
02/07/202423:28Alliance NewsAlliance NewsGLOBAL BRIEFING: Europe called up as Powell revives rate cut hopes
02/07/202423:19GlobeNewswire Inc.Yantai Exhibition Celebrates 27th Anniversary of Hong Kong's Return to Motherland
02/07/202423:18NEWSBTCXRP Price Dip: Should Investors See This as a Buying Chance?COIN:ETHUSDEthereum
02/07/202423:15PR Newswire (US)/C O R R E C T I O N -- Wormington & Bollinger/
02/07/202423:10PR Newswire (US)Persistent Acquires Starfish Associates, Strengthening its Position in AI-powered Contact Center and Unified Communications
02/07/202423:01PR Newswire (US)HOME AFFORDABILITY GETS TOUGHER DURING SECOND QUARTER ACROSS U.S. AS PRICES SHOOT BACK UP
02/07/202423:00NEWSBTCETH Price Dips As Ethereum ETF Approval Faces DelayCOIN:BTCUSDBitcoin
02/07/202423:00PR Newswire (US)New Novel Illustrates What Loss Of Liberty Could Look Like
02/07/202423:00PR Newswire (US)Summer is High Time to Visit the Tennessee River Valley in Georgia's Coolest Place
02/07/202423:00PR Newswire (US)Be The Best You Can Be, Take Advantage Of The Opportunities Presented, And Never Give Up
02/07/202423:00PR Newswire (US)Fans Can Return to Aeramor As The Heavenly Places Series Continues With Book Two
02/07/202423:00PR Newswire (US)God Is Ready And Willing To Walk With His Children Through Their Difficulties
02/07/202423:00PR Newswire (US)While Many Around America Are Acting Out Of Hate, One Author Believes The Solution Is Love
02/07/202423:00PR Newswire (US)Eye-Opening Fictional Story Takes Readers on a Journey Into An Uncharted Territory to Bring Critical Answers to Light
02/07/202423:00PR Newswire (US)Your Doctor Has A Plan For Treating Cancer; So Does God
02/07/202423:00PR Newswire (US)In a World Full of Adversities and Difficulties, Faith and Trust in Jesus is Key
02/07/202423:00PR Newswire (US)Author Shares Riveting First-Hand Experience With Veteran Husband's PTSD
02/07/202423:00PR Newswire (US)Author Shares Lessons Learned; A Journey From Wanting to Quit Marriage, Faith and Life to Enduring, Persevering and Overcoming
02/07/202423:00PR Newswire (US)A Month's Worth Of Devotions Inspired By Real Life Experiences
02/07/202423:00PR Newswire (US)New Novel Explores The Christian Experience For Former Muslims
02/07/202422:48GlobeNewswire Inc.OKX Wallet Now Integrated with Ref Finance, a DeFi Platform Built on NEAR

Su Consulta Reciente

NYSE
XOM
Exxon Mobil
PM
XAUUSD
Gold vs US Dollar
NASDAQ
AAPL
Apple
NYSE
DIS
Walt Disney
SPI
SP500
S&P 500
AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
CCOM
US500
US 500
NASDAQ
MSFT
Microsoft
NYSE
BAC
Bank of America
NASDAQ
NVDA
NVIDIA
NASDAQ
TSLA
Tesla
COIN
ETHUSD
Ethereum
FX
EURUSD
Euro vs US Dollar
USOTC
DTEGY
Deutsche Telekom (QX)
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados